AC Immune SA (ACIU)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-08-01 | Phase1 Readout | — |
| 2026-11-01 | Phase1 Readout | — |
Active Clinical Trials (5)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT05462106 | A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) | PHASE2 | Recruiting | 304 |
| NCT06015841 | A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease | PHASE2 | Active Not Recruiting | 150 |
| NCT06891716 | [18F]ACI-19626 PET in TDP-43 Proteinopathies | PHASE1 | Recruiting | 45 |
| NCT07463196 | A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy P... | PHASE1 | Recruiting | 78 |
| NCT06891703 | [18F]ACI-15916 PET in α-synucleinopathies | PHASE1 | Recruiting | 46 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.